| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 93 |
| 1 | PREDNISONE | 92 |
| 2 | METHOTREXATE | 86 |
| 3 | ADALIMUMAB | 74 |
| 4 | FUROSEMIDE | 74 |
| 5 | ALBUTEROL SULFATE | 65 |
| 6 | OMEPRAZOLE MAGNESIUM | 64 |
| 7 | ASPIRIN | 62 |
| 8 | METOPROLOL TARTRATE | 58 |
| 9 | ASPIRIN 325 MG | 57 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SERTACONAZOLE NITRATE | 6 | 0.0370 |
| 1 | L DOPA | 7 | 0.0261 |
| 2 | PENTAMIDINE ISETHIONATE | 5 | 0.0040 |
| 3 | SILODOSIN | 13 | 0.0032 |
| 4 | GRANULOCYTE COLONY STIMULATING FACTOR | 5 | 0.0023 |
| 5 | ATOVAQUONE | 14 | 0.0017 |
| 6 | HYDRALAZINE HYDROCHLORIDE | 4 | 0.0015 |
| 7 | AXICABTAGENE CILOLEUCEL | 15 | 0.0015 |
| 8 | GLYCOPYRROLATE | 8 | 0.0014 |
| 9 | BOTULINUM TOXIN TYPE A | 17 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 238 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 132 |
| 2 | Benzodiazepine [EPC] | 125 |
| 3 | Platinum-based Drug [EPC] | 106 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 102 |
| 5 | Proton Pump Inhibitor [EPC] | 98 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 90 |
| 7 | Kinase Inhibitor [EPC] | 84 |
| 8 | Loop Diuretic [EPC] | 82 |
| 9 | Opioid Agonist [EPC] | 70 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Stimulating Hormone [EPC] | 3 | 0.0029 |
| 1 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 2 | Aldehyde Dehydrogenase Inhibitor [EPC] | 2 | 0.0018 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 15 | 0.0015 |
| 4 | Antimalarial [EPC] | 15 | 0.0014 |
| 5 | Antiprotozoal [EPC] | 15 | 0.0014 |
| 6 | Actinomycin [EPC] | 3 | 0.0014 |
| 7 | Rifamycin Antimycobacterial [EPC] | 4 | 0.0011 |
| 8 | Asparagine-specific Enzyme [EPC] | 14 | 0.0010 |
| 9 | Monobactam Antibacterial [EPC] | 2 | 0.0007 |